Podophyllotoxin-induced acantholysis and cytolysis in a skin equivalent model

European Journal of Morphology

Volumn 36, Issue 3, 1998, Pages 183-187

  Hermanns Lê, Trinh ^a   Arrese, Jorge E ^a   Goffin, Véronique ^a   Piérard, Gérald E ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Acantholysis; Cantharidin; Cosmetics; Podophyllotoxin; Skin equivalent; Toxicity

Indexed keywords

PODOPHYLLOTOXIN;

ACANTHOLYSIS; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CYTOLYSIS; HUMAN; MODEL; MOLLUSCUM CONTAGIOSUM; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TOXICITY TESTING; VIRAL SKIN DISEASE;

EID: 0031728637     PISSN: 09243860     EISSN: None     Source Type: Journal    
DOI: 10.1076/ejom.36.3.183.4768     Document Type: Article

References (12)

1. Augustin C, Frei V, Pernier E, Huc A, Damour O (1997) A skin equivalent model for cosmetological trials: an in vitro efficacy study of a new biopeptide. Skin Pharmacol 10: 63-70.
2. Deleixhe-Mauhin F, Piérard-Franchimont C. Piérard GE (1991) Podophyllotoxin in the treatment of molluscum contagiosum. J Dermatol Treat 2: 99-101.
3. Manso-Martinez R (1982) Podophyllotoxin poisoning of microtubules at steady-state: effect of substoichiometric and superstoichiometric concentrations of drug. Mol Cell Biochem 45: 3-11.
4. Marurkiewicz, W, Jablonska S (1990) Clinical efficacy of condyline (0.5% podophyllotoxin) solution and cream versus podophyllin in the treatment of external condylomata acuminata. J Dermatol Treat 1: 123-125.
5. Piérard GE, Coffin V, Hermanns-Lê T, Arrese JE, Piérard-Franchimont C (1995) Surfactant induced dermatitis. A comparison of corneosurfametry with predictive testing on human and reconstructed skin. J Am Acad Dermatol 33: 462-469.
6. Piérard-Franchimont C, Piérard GE (1988) Cantharidin-induced acantholysis. Am J Dermatopathol 10: 419-423.
7. Ponec M, Kempenaar J (1995) Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacol 8: 49-59.
8. Rognet R, Regnier M, Cohen C, Dossou G, Rougier A (1994) The use of in vitro reconstituted human skin in dermotoxicity testing. In Vitro Toxicol 8: 635-639.
9. Slivka SR, Landeen LK, Zeigler F, Zimber MP, Bartel RL (1993) Characterization, barrier function, and drug metabolism of an in vitro skin model. J Invest Dermatol 100: 40-46.
10. Slivka SR, Zeigler F (1993) Use of an in vitro skin model for determining epidermal and dermal contributions to irritant responses. J Toxicol Cutan Ocular Toxicol 12: 49-57.
11. Stoppie P, Borghgraef P, De Wever B, Geysen J, Borgers M (1992) The epidermal architecture of an in vitro reconstructed human skin equivalent. Eur J Morphol 30: 280-283.
12. Van Krogh G, Maibach HI (1982) Cutaneous cytodestructive potency of lignans. A comparative evaluation on epidermal and dermal DNA synthesis and on dermal microcirculation in the hairless mouse. Arch Dermatol 274: 9-20.